{{Rsnum
|rsid=11651483
|Gene=ARHGAP44
|Chromosome=17
|position=12874085
|Orientation=plus
|GMAF=0.2828
|Gene_s=ARHGAP44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 15.9 | 83.2
| HCB | 12.4 | 39.4 | 48.2
| JPT | 13.3 | 47.8 | 38.9
| YRI | 34.7 | 51.7 | 13.6
| ASW | 30.4 | 46.4 | 23.2
| CHB | 12.4 | 39.4 | 48.2
| CHD | 9.2 | 44.0 | 46.8
| GIH | 5.0 | 38.6 | 56.4
| LWK | 48.2 | 40.9 | 10.9
| MEX | 5.2 | 29.3 | 65.5
| MKK | 29.2 | 46.8 | 24.0
| TSI | 2.0 | 14.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=3E-7
  |OR=1.36
  |ORtxt=[1.12-1.643]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}